The Epilepsy Study Consortium: Clinical Trials

8 trials sponsored by The Epilepsy Study Consortium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 terminated. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 12Completed 1, Terminated 1

Follow The Epilepsy Study Consortium: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Double Blind, Randomized, Cross-over Study Examining the Suppression of the Photoparoxysmal EEG Response With NPT 2042
NPT 2042 - Photosensitive Epilepsy, Epilepsy
Phase 1CompletedNeuroPro Therapeutics, Inc.52024-08-212025-07-16
Safety, Tolerability, and Efficacy of RLS103 in a Clinical Model of Photosensitive Epilepsy
High dose RLS103, placebo inhaled powder, Low dose RLS103 - Epilepsy
Phase 1TerminatedReceptor Life Sciences22022-04-252024-05-02
Human Epilepsy Project 2: Resistant Focal Seizures Study
Epilepsy, Brain Diseases
CompletedEpilepsy Foundation of America1572018-05-072023-09-18
Staccato Alprazolam and Photoparoxysmal Response
A=Placebo, B=Inhaled Alprazolam 0.5 mg, C=Inhaled Alprazolam 1 m - Epilepsy
Phase 2CompletedNova Pneuma Inc.52015-01-012026-04-20
The Human Epilepsy Project
Focal Epilepsy
CompletedNYU Langone Health4882012-07-012021-07-06
Assessment of Suicidality in Epilepsy - Rating Tools
Epilepsy
CompletedThe Epilepsy Study Consortium2002010-01-012012-03-05
Photosensitivity Proof of Concept Trial
carbamazepine 400mg, levetiracetam 1000mg - Photosensitive Epilepsy
Phase 2CompletedThe Epilepsy Study Consortium62009-05-012012-03-05
Efficacy of YKP3089 in Patients With Photosensitive Epilepsy
YKP3089, Placebo - Epilepsy
Phase 2CompletedSK Life Science, Inc.112007-08-012014-01-31

Conditions studied

Epilepsy (8)  ·  Epilepsy, Reflex (2)  ·  Seizures (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Epilepsies, Partial (1)  ·  Nervous System Diseases (1)  ·  Photosensitivity Disorders (1)

Interventions

Carbamazepine (1)  ·  Cenobamate (1)  ·  Levetiracetam (1)

Countries

United States (7)  ·  Australia (1)  ·  Canada (1)

Top investigators

Jacqueline French, M.D. (3)  ·  Daniel Lowenstein, MD (2)  ·  Jacqueline French, MD (2)  ·  Ruben Kuzniecky, MD (2)  ·  Andres Kanner, M.D. (1)  ·  Brandy Fureman, PhD (1)  ·  Dale Hesdorffer, PhD, MPH (1)  ·  J Isojarvi, MD (1)  ·  Kelly Posner, PhD (1)

Results publications

PMID 31292226, PMID 40853673